By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
IndebtaIndebta
  • Home
  • News
  • Banking
  • Credit Cards
  • Loans
  • Mortgage
  • Investing
  • Markets
    • Stocks
    • Commodities
    • Crypto
    • Forex
  • Videos
  • More
    • Finance
    • Dept Management
    • Small Business
Notification Show More
Aa
IndebtaIndebta
Aa
  • Banking
  • Credit Cards
  • Loans
  • Dept Management
  • Mortgage
  • Markets
  • Investing
  • Small Business
  • Videos
  • Home
  • News
  • Banking
  • Credit Cards
  • Loans
  • Mortgage
  • Investing
  • Markets
    • Stocks
    • Commodities
    • Crypto
    • Forex
  • Videos
  • More
    • Finance
    • Dept Management
    • Small Business
Follow US
Indebta > Investing > ADRs End Higher, Yunji and Connect Biopharma Trade Actively
Investing

ADRs End Higher, Yunji and Connect Biopharma Trade Actively

News Room
Last updated: 2023/06/03 at 11:00 PM
By News Room
Share
1 Min Read
SHARE

By Denny Jacob


International stocks trading in New York closed higher on Friday.

The S&P/BNY Mellon index of American depositary receipts rose 1.5% to 151.37. The European index advanced 1.2% to 147.41. The Asian index climbed 1.7% to 173.32. The Latin American index surged 2.9% to 193.24, while the emerging-markets index moved up 1.5% to 287.98.

Yunji was among those whose ADRs traded actively. The social e-commerce platforms provider soared 51% after narrowing its loss in the latest quarter.

Connect Biopharma Holdings rose 9.9% a day after the clinical-stage biopharmaceutical company reported positive data at Week 48 from Phase 2 trial for icanbelimod, which is being developed as a treatment of ulcerative colitis.


Write to Denny Jacob at denny.jacob@wsj.com


Read the full article here

News Room June 3, 2023 June 3, 2023
Share this Article
Facebook Twitter Copy Link Print
Leave a comment Leave a comment

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Finance Weekly Newsletter

Join now for the latest news, tips, and analysis about personal finance, credit cards, dept management, and many more from our experts.
Join Now
Powell tells Trump that Federal Reserve’s interest rate policy will depend on data and outlook

Unlock the White House Watch newsletter for freeYour guide to what Trump’s…

Former Goldman Sachs banker sentenced to two years in prison for 1MDB role

Unlock the Editor’s Digest for freeRoula Khalaf, Editor of the FT, selects…

The VC industry needs a geopolitical reboot

Unlock the Editor’s Digest for freeRoula Khalaf, Editor of the FT, selects…

White House moves to overturn ruling that Trump’s tariffs are illegal

Unlock the White House Watch newsletter for freeYour guide to what Trump’s…

EU-US trade talks to go ahead despite court blow to Donald Trump’s tariffs

Unlock the Editor’s Digest for freeRoula Khalaf, Editor of the FT, selects…

- Advertisement -
Ad imageAd image

You Might Also Like

Investing

Nursing Home Stocks Could Suffer from this Medicaid Spending Remedy

By News Room
Investing

Bitcoin Drops Below $90,000 Again. What Could Move It Next.

By News Room
Investing

These Stocks Are Moving the Most Today: Marvell, Nvidia, Broadcom, GM, Tesla, MongoDB, Burlington, and More

By News Room
Investing

Nvidia Stock Falls as Marvell Earnings Compound AI Gloom. The Rising Risks for Chips.

By News Room
Investing

This analyst says Tesla deliveries will be 16% below expectations. Musk is part of the problem.

By News Room
Investing

BP CEO was awarded no bonus pay from oil giant’s financial performance

By News Room
Investing

Shares of Starlink’s European competitor have tripled. CEO says it can do the job in Ukraine.

By News Room
Investing

GE Vernova Stock Rises as Analyst Flips to Upgrade After Rating Cut

By News Room
Facebook Twitter Pinterest Youtube Instagram
Company
  • Privacy Policy
  • Terms & Conditions
  • Press Release
  • Contact
  • Advertisement
More Info
  • Newsletter
  • Market Data
  • Credit Cards
  • Videos

Sign Up For Free

Subscribe to our newsletter and don't miss out on our programs, webinars and trainings.

I have read and agree to the terms & conditions
Join Community

2023 © Indepta.com. All Rights Reserved.

Welcome Back!

Sign in to your account

Lost your password?